Related Experiment Video
Updated: Jun 17, 2026
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Microbial polysaccharide: new insights for treating autoimmune diseases
Anna Vecchiarelli1, Claudia Monari
1Department of Experimental Medicine and Biochemical Sciences, Microbiology Section, University of Perugia, Perugia 06122, Italy. vecchiar@unipgit
Frontiers in Bioscience (Scholar Edition)
|December 29, 2009
Summary
Glucuronoxylomannan (GXM) from Cryptococcus neoformans suppresses immune cells, offering potential as an anti-inflammatory therapy. This review highlights GXM
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Glucuronoxylomannan (GXM) is a capsular polysaccharide from Cryptococcus neoformans.
- GXM exhibits significant immunosuppressive properties affecting both innate and adaptive immunity.
Purpose of the Study:
- To review the anti-inflammatory role of GXM.
- To discuss the potential clinical applications of GXM as a therapeutic agent.
Main Methods:
- Literature review of studies on GXM's immunomodulatory effects.
- Analysis of GXM's impact on proinflammatory and autoimmune responses.
Main Results:
- GXM inhibits key immune cell functions.
- GXM effectively reduces both proinflammatory and autoimmune inflammation.
- GXM demonstrates potential as a novel anti-inflammatory agent.
Conclusions:
- GXM's immunosuppressive capabilities position it as a promising candidate for anti-inflammatory therapies.
- Further research and clinical trials are warranted to explore GXM's therapeutic potential.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...